Jay Shetty suffers from a debilitating form of cerebral palsy and autism since he was a baby, which means he cannot walk, talk or sit up unaided.
He is now set to undergo a pioneering clinical trial at Duke University Medical Centre in North Carolina, which relies on the infusion of his younger brother's umbilical cord blood frozen at birth.
She and husband Raj had the umbilical cord blood of their younger child frozen and stored by UK-based blood bank Cells4Life.
Umbilical cord blood is rich in a kind of stem cell that can, in theory, help heal most parts of the body, either by stimulating growth or by transforming into the required type of mature cell.
When the Shettys contacted Duke University, they were told that Kairav's blood was a match for Jay's raising the prospect of the UK's first such sibling cord blood therapy on Jay.
Stem cell is a cure for some and improvement for all, so we are pretty sure it will definitely have some improvement in Jay's life, said Shilpa.
The family from Maharashtra, who have been based in London for over 15 years, are determined not to be put off by some dissenting voices within the medical community who cast doubts on the rare procedure.
It is in its early stages and it has always been the norm that people will doubt treatments which have not been proved yet. But stem cells in general after years of proven research are known to have the ability to reach the damaged organ and regenerate new cells, she said.
Claudia Rees, Operations Director at Cells4Life, describes the procedure as a cutting-edge treatment, considered a cornerstone of a relatively new area of science known as regenerative medicine.
Cells4Life believes the results of Jay's procedure will be very exciting, made possible by parents choosing to bank their children's cord blood at birth at an estimated cost of around 2,000 pounds.
Jay will be in the US for the treatment for a week and undergo rehabilitation in the UK after the cord blood transfusion procedure. The family have managed to raise nearly 26,000 pounds through fundraising to assist with the massive costs involved.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹810
1 Year
₹67/Month
Super Saver
₹1,170
2 Years
₹48/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories
Over 30 subscriber-only stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app